» Articles » PMID: 29134312

Refining the Definitions of Biochemical and Clinical Cure for Primary Aldosteronism Using the Primary Aldosteronism Surgical Outcome (PASO) Classification System

Overview
Journal World J Surg
Publisher Wiley
Specialty General Surgery
Date 2017 Nov 15
PMID 29134312
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Determination of outcomes after adrenalectomy for primary aldosteronism (PA) is limited by the lack of standardized definitions of cure. The Primary Aldosteronism Surgical Outcomes (PASO) group recently established new consensus definitions for biochemical and clinical cure of PA. We hypothesize that utilization of PASO definitions will better stratify patient outcomes after surgery compared to original and current criteria utilized to document cure.

Materials And Methods: Patients undergoing adrenalectomy for PA from 1996 to 2016 were studied. Clinical data were reviewed. Three different sets of criteria (original, current, and PASO) were evaluated for differences in documentation of cure. Demographic data were reported as median (range). Comparisons were made using the Mann-Whitney U test; p < 0.05 is significant.

Results: A total of 314 patients with PA were identified. Ninety patients (60 males) elected to proceed with surgery. In Group 1 (35 patients), 30 patients had clinical follow-up and 29 (97%) were cured using original criteria. In Group 2 (55 patients), cure was recorded in 98% when original criteria for cure were applied, 89% cured applying current criteria, and 6% had complete biochemical and clinical cure by PASO criteria. Aldosterone rose 3.6 ng/dL (0.1-34.8) in five patients during extended follow-up, with two patients changing from complete to partial or missing biochemical success.

Conclusion: Significant heterogeneity exists in outcomes criteria utilized to document cure or clinical improvement after adrenalectomy for primary aldosteronism. Aldosterone levels change over time after adrenalectomy. PASO definitions of cure appear to allow for improved stratification of short- and long-term outcomes.

Citing Articles

Ga-pentixafor PET/CT in guiding surgical management of primary aldosteronism.

Zheng G, Ding J, Gao Y, Liu S, Yan X, Wang W J Clin Transl Endocrinol. 2025; 39:100384.

PMID: 39926105 PMC: 11803161. DOI: 10.1016/j.jcte.2025.100384.


Safety and efficacy of bilateral superselective adrenal arterial embolization for treatment of idiopathic hyperaldosteronism: a prospective single-center study.

Mao M, Feng R, Khan N, Tao L, Tang P, Zhao Y BMC Surg. 2024; 24(1):242.

PMID: 39182043 PMC: 11344387. DOI: 10.1186/s12893-024-02530-z.


Predictors of successful outcome after adrenalectomy for unilateral primary aldosteronism.

Saadi A, Bedoui M, Zaghbib S, Boussaffa H, Mokaddem S, Ben Nacef I Front Endocrinol (Lausanne). 2023; 14:1205988.

PMID: 37635962 PMC: 10454906. DOI: 10.3389/fendo.2023.1205988.


Biochemical Evaluation by Confirmatory Tests after Unilateral Adrenalectomy for Primary Aldosteronism.

Murasawa S, Kageyama K, Usutani M, Asari Y, Kinoshita N, Nakada Y J Renin Angiotensin Aldosterone Syst. 2023; 2023:5732812.

PMID: 37265473 PMC: 10232090. DOI: 10.1155/2023/5732812.


Clinical cure vs a novel trifecta system for evaluating long-term outcomes of minimally-invasive partial or total adrenalectomy for unilateral primary aldosteronism: results of a multicentric series.

Anceschi U, Tufano A, Flammia R, Mormando M, Fiori C, Zappala O Cent European J Urol. 2023; 75(4):345-351.

PMID: 36794029 PMC: 9903164. DOI: 10.5173/ceju.2022.147.


References
1.
Young W, Stanson A, Thompson G, Grant C, Farley D, van Heerden J . Role for adrenal venous sampling in primary aldosteronism. Surgery. 2005; 136(6):1227-35. DOI: 10.1016/j.surg.2004.06.051. View

2.
Mulatero P, Stowasser M, Loh K, Fardella C, Gordon R, Mosso L . Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004; 89(3):1045-50. DOI: 10.1210/jc.2003-031337. View

3.
Minami I, Yoshimoto T, Hirono Y, Izumiyama H, Doi M, Hirata Y . Diagnostic accuracy of adrenal venous sampling in comparison with other parameters in primary aldosteronism. Endocr J. 2008; 55(5):839-46. DOI: 10.1507/endocrj.k07e-164. View

4.
Rossi G, Barisa M, Allolio B, Auchus R, Amar L, Cohen D . The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism. J Clin Endocrinol Metab. 2012; 97(5):1606-14. DOI: 10.1210/jc.2011-2830. View

5.
Jazayeri A, Meyer 3rd W . Mineralocorticoid-induced increase in beta-adrenergic receptors of cultured rat arterial smooth muscle cells. J Steroid Biochem. 1989; 33(5):987-91. DOI: 10.1016/0022-4731(89)90250-1. View